Hunterase (recombinant human iduronate-2-sulfatase) / GC Biopharma, CANbridge Pharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hunterase (recombinant human iduronate-2-sulfatase) / GC Biopharma
NCT02663024: Study of Idursulfase-beta (GC1111) in Hunter Syndrome

Unknown status
2
20
NA
idursulfase beta, GC1111, idursulfase, Elaprase
Green Cross Corporation
Mucopolysaccharidosis II
12/19
06/20
NCT01301898: To Evaluate the Safety and Efficacy of GC1111 (Recombinant Human Iduronate-2-sulfatase) in Hunter Syndrome Patients

Completed
1/2
31
RoW
GC1111_0.5mg/kg, GC1111_1.0mg/kg, Elaprase_0.5mg/kg
Green Cross Corporation
Mucopolysaccharidosis II
03/11
03/11

Download Options